Prosport Heat Spray
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Prosport Heat Spray
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
2-hydroxyethyl salicylate 5%w/w
Diethylamine salicylate 5%w/w
Methyl nicotinate 1%w/w
3 PHARMACEUTICAL FORM
Spray for topical administration
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
For the symptomatic relief of muscular and rheumatic pain.
4.2 Posology and method of administration
There is no difference between the dosage for adults, children or the elderly.
Shake the can well before use. Holding the can about 6 inches from the skin surface, point nozzle arrow towards painful area. Spray evenly using short bursts. There is no need to massage.
Do not use on children under five years of age.
Prosport Heat Spray is for external use only. Do not allow the spray to enter the eyes. Do not use on skin which is inflamed or broken or where there is known hypersensitivity to salicylates.
4.4 Special warnings and precautions for use
Caution, Prosport Heat Spray is flammable. Do not use near fire or flame.
Pressurized container: Protect from sunlight and do not expose to temperatures exceeding 50°C.
Keep away from the eyes, nose and other sensitive areas.
Do not pierce or burn the can, even after use.
Do not spray on a naked flame or any incandescent material.
Do not use near, and do not place the container on, polished or painted surfaces. Keep out of the reach of children.
4.5 Interaction with other medicinal products and other forms of interaction
None known.
4.6 Pregnancy and lactation
As with all medicinal compounds care should be taken when administering the product to pregnant or lactating women
4.7 Effects on ability to drive and use machines
None known.
4.8 Undesirable effects
After application a slight transient erythema may develop.
Owing to the nature of this product and its clinical indications it is highly unlikely overdose can occur.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
The active ingredients of Prosport Heat Spray are commonly found in topical analgesic and rubefacient preparations. 2-hydroxyethyl salicylate is a rubefacient as is methyl nicotinate and diethylamine salicylate is a topical analgesic for rheumatic and muscular pain
5.2 Pharmacokinetic properties
Methyl nicotinate percutaneous absorption may occur dependent on the vehicle base and is via the intercellular route. There is no evidence to suggest that percutaneous absorption of the other constituents occurs to any great extent.
5.3 Preclinical safety data
Not applicable.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Isopropyl alcohol
Butane propellant
6.2 Incompatibilities
None known.
6.3
Shelf life
36 months unopened.
Special precautions for storage
6.4
Protect from sunlight and do not expose to temperatures exceeding 50°C.
6.5 Nature and contents of container
Internally lacquered, three piece, tin plate aerosol can containing 125m1 or 150m1 of product with a standard aerosol valve and high density polyethylene cap.
6.6 Special precautions for disposal
Not applicable.
7 MARKETING AUTHORISATION HOLDER
AYRTON SAUNDERS LIMITED NORTH WAY
WALWORTH INDUSTRAIL ESTATE
ANDOVER
SP10 5AZ
8 MARKETING AUTHORISATION NUMBER(S)
PL 16431/0077
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
31 August 1993 / 17 November 1998
10. DATE OF (PARTIAL) REVISION OF THE TEXT
29 January 2008